Earth Life Sciences (CLTS) Stock Statistics & Valuation Metrics
Total Valuation
Earth Life Sciences has a market cap or net worth of $99.99K. The enterprise value is $394.14B.
- Market Cap
- $99.99K
- Enterprise Value
- $394.14B
Share Statistics
Earth Life Sciences has 999,891,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 999,891,600
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Earth Life Sciences’s return on equity (ROE) is -0.39 and return on invested capital (ROIC) is -35.95%.
- Return on Equity (ROE)
- -0.39
- Return on Assets (ROA)
- -0.36
- Return on Invested Capital (ROIC)
- -35.95%
- Return on Capital Employed (ROCE)
- -0.39
- Revenue Per Employee
- 0
- Profits Per Employee
- -21.41K
- Employee Count
- 74
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Earth Life Sciences is -0.03. Earth Life Sciences’s PEG ratio is 0.00.
- PE Ratio
- -0.03
- PS Ratio
- 0.00
- PB Ratio
- 0.01
- Price to FCF
- -6.30
- Price to Operating Cash Flow
- -3.12
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Earth Life Sciences had revenue of 0 and earned -1.58M in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -1.56M
- Pretax Income
- -1.58M
- Net Income
- -1.58M
- EBITDA
- -35
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was 800.01M and capital expenditures 0, giving a free cash flow of 800.01M billion.
- Operating Cash Flow
- 800.01M
- Free Cash Flow
- 800.01M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Earth Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -15.87%
- Earnings Yield
- -3202.30%
Stock Price Statistics
- Beta
- -18.65
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Earth Life Sciences as a current ratio of 0.00, with Debt / Equity ratio of 7.26%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- 0.00
- Interest Coverage Ratio
- -72.60
Taxes
In the past 12 months, Earth Life Sciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Earth Life Sciences EV to EBITDA ratio is -11261.20, with an EV/FCF ratio of -24.84.
- EV to Sales
- 0.00
- EV to EBITDA
- -11261.20
- EV to Free Cash Flow
- -24.84
- EV to Operating Cash Flow
- -24.84
Balance Sheet
Earth Life Sciences has -$46.90K in cash and marketable securities with $267.75K in debt, giving a net cash position of -$314.65K billion.
- Cash & Marketable Securities
- -$46.90K
- Total Debt
- $267.75K
- Net Cash
- -$314.65K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Earth Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―